U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 4, 2011, Pages 591-599

  Horner, Marie Josèphe ^a   Altekruse, Sean F ^a   Zou, Zhaohui ^b   Wideroff, Louise ^c   Katki, Hormuzd A ^a   Stinchcomb, David G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; POVERTY; PRIORITY JOURNAL; RACE; UNITED STATES; UTERINE CERVIX CANCER; VITAL STATISTICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79955774150     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1183     Document Type: Article

References (40)

1. What are the key statistics about cervical cancer? [Internet]Atlanta, GA: American Cancer Society, Cancer Reference Information [Cited 2010 Apr 23]. Available from: http://www.cancer.org/Cancer/CervicalCancer/ DetailedGuide/cervical-cancer-key-statistics.
2. American Cancer Society. Cancer facts & figures 2010. Atlanta, GA: American Cancer Society; 2010.
3. Cancer Trends Progress Report-2009/2010 Update [Internet]. Bethesda, MD: National Cancer Institute[Cited 2010 Apr 23]. Available from:http:// progressreport.cancer.gov.
4. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socio-economic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004;101:1051-7.
5. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009; 20:417-35.
6. Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008;113:2855-64.
7. Coughlin SS, Richards TB, Nasseri K, Weiss NS, Wiggins CL, Saraiya M, et al. Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003. Cancer 2008;113:2964-73.
8. Freeman HP, Wingrove BK, editors. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005. [NIH Pub. No. 05-5282].
9. Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 2006;15:2154-9.
10. Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M. Risk estimation for the next generation of prevention programs for cervical cancer. Lancet Oncol 2009;10:1022-3.
11. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Mistro AD, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial. Lancet Oncol 2010;11:249-57.
12. Castle PE, Katki HA. Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncol 2010;11:214-5.
13. Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 2008;113:1980-93.
14. Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WG, Wheeler CM. New technologies in cervical cancer screening. Vaccine 2008;26 Suppl 10:K42-52.
15. World Health Organization. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009;84:117-32.
16. Mokdad AH. The behavioral risk factors surveillance system: past, present, and future. Annu Rev Public Health 2009;30:43-54.
17. National Health Interview Survey [Internet]. Atlanta, GA: Centers for Disease Control and Prevention [last updated 2009 June 17; cited 2010 Apr 23]. Available from:http://www.cdc.gov/nchs/nhis/about-n-his. htm.
18. Census 2000 Summary File 3 [Internet]Suitland, MD: U.S. Census Bureau[cited 2010 Apr 23]. Available from:http://factfinder.census. gov/servlet/DatasetMainPageServlet
19. Raghunathan TE, Xie D, Schenker N, Parsons V, Davis WW, Dodd KW, et al. Combining information from two surveys to estimate county-level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 2007;102:474-86.
20. Model-based small area estimates of cancer risk factors & screening behaviors [Internet]. Bethesda, MD: National Cancer Institute[Cited 2010 Apr 23]. Methodology for the Model-Based Small Area Estimates. Available from:http://sae.cancer.gov/understanding/methodology. html
21. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER Summary Staging Manual-2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute, National Institutes of Health; 2001. [NIH Pub. No. 01-4969].
22. Pickle LW, Hao Y, Jemal A, Zou Zhaohui, Tiwari R, Ward E, et al. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin 2007; 57:30-42. (Pubitemid 46148090)
23. Pickle LW, Feuer EJ, Edwards BK, editors. U.S. predicted cancer incidence, 1999: complete maps by county and state from spatial projection models. Bethesda, MD: National Cancer Institute; 2003. [NCI Cancer Surveillance Monograph Series, No. 5].
24. Pickle LW, Feuer EJ, Edwards BK. Predicting cancer incidence in non- SEER counties. Proceedings of the Biometrics Section of the 2000 Annual Meeting of the American Statistical Association 2001. p. 45-52
25. Rural-urban continuum codes [Internet]. Washington, DC: U.S. Department of Agriculture[updated 2004 Nov 3; cited 2010 Apr 23]. Available from:http://www.ers.usda.gov/data/RuralUrbanContinuum- Codes/.
26. Area Resource File 2006 [Internet]. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions; [cited 2010 Apr 23]. Available from:http://arf.hrsa.gov/.
27. Policy for Calculating Hispanic Mortality (1990-2004) [Internet]. Bethesda, MD: National Cancer Institute. [cited 2010 Apr 23] Available from: http://seer.cancer.gov/seerstat/variables/mort/origin- recode-1990±/ yr1969-2004/
28. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-45. (Pubitemid 35277277)
29. Mungiole M, Pickle LW, Simonson KH. Application of a weighted head-banging algorithm to mortality data maps. Stat Med 1999;18:3201-9.
30. Trimble EL, Harlan LC, Clegg LX. Untreated cervical cancer in the United States. Gynecol Oncol 2005;96:271-7. (Pubitemid 40127120)
31. Lengerich EJ, Tucker TC, Powell RK, Colsher P, Lehman E, Ward AJ, et al. Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia. J Rural Health 2005;21:39-47. (Pubitemid 40052512)
32. McLafferty S, Wang F. Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois. Cancer 2009;115:2755-64.
33. Scarinci IC, Garcia FAR, Kobetz E, Partridge EE, Brandt HM, Bell MC, et al. Cervical cancer prevention, new tools and old barriers. Cancer 2010; 116:2531-42.
34. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years-United States, 2010. MMWR 2010;58:1-4.
35. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR 2009;58:997-1001.
36. Bach PB. Gardasil: from bench, to bedside, to blunder. Lancet 2010;375:963-4.
37. Gomez SL, Glaser SL. Quality of cancer registry birthplace data for Hispanics living in the United States. Cancer Causes Control 2005;16:713-23. (Pubitemid 41110962)
38. Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18:177-87.
39. Kim JJ, Ortendahl J, Goldie SJ. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med 2009;151:538-45.
40. Yabroff KR, Saraiya M, Meissner HI, Haggstrom DA, Wideroff L, Yuan G, et al. Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med 2009;151:602-11.